Thermofisher Efficient Purification for Next Gen Antibodies

Monoclonal antibodies (mAbs) and next-generation antibodies such as bispecific antibodies and antibody-drug conjugates (ADCs) are transforming the therapeutic landscape—but they also introduce complex purification challenges. Traditional methods often fall short, leading to higher costs and lower yields.

This eBook provides expert insights into overcoming these hurdles and explores advanced downstream processing strategies that improve yield, reduce costs, and streamline manufacturing.

Download this eBook to learn:

• Key trends in antibody therapeutic development
• Solutions for bispecific antibodies, fragments, and ADCs
• Practical steps to reduce cost and improve yield